Additional diagnostic criteria for APS-1 can be the identification of specific biomarkers—autoantibodies to interleukin 22 (IL-22) [5,6] and type I interferons [7]. This evidence concerns the gene IL22 and autoimmune polyendocrine syndrome type 1.